AU2001267638A1 - Combinatorial production of nucleotide and nucleoside (xitp)analogues - Google Patents

Combinatorial production of nucleotide and nucleoside (xitp)analogues

Info

Publication number
AU2001267638A1
AU2001267638A1 AU2001267638A AU2001267638A AU2001267638A1 AU 2001267638 A1 AU2001267638 A1 AU 2001267638A1 AU 2001267638 A AU2001267638 A AU 2001267638A AU 2001267638 A AU2001267638 A AU 2001267638A AU 2001267638 A1 AU2001267638 A1 AU 2001267638A1
Authority
AU
Australia
Prior art keywords
xitp
nucleoside
analogues
nucleotide
combinatorial production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001267638A
Other versions
AU2001267638B2 (en
Inventor
Philippe Marliere
Sylvie Pochet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0007557A external-priority patent/FR2810322B1/en
Application filed by Centre National de la Recherche Scientifique CNRS, Institut Pasteur de Lille filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2001267638A1 publication Critical patent/AU2001267638A1/en
Application granted granted Critical
Publication of AU2001267638B2 publication Critical patent/AU2001267638B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001267638A 2000-06-14 2001-06-13 Combinatorial production of nucleotide and nucleoside (xitp)analogues Ceased AU2001267638B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0007557A FR2810322B1 (en) 2000-06-14 2000-06-14 COMBINATORY PRODUCTION OF NUCLEOTIDE AND NUCLEOTIDE ANALOGUES (XiTP)
FR00/07557 2000-06-14
PCT/FR2001/001830 WO2001096354A1 (en) 2000-06-14 2001-06-13 Combinatorial production of nucleotide and nucleoside (xitp)analogues

Publications (2)

Publication Number Publication Date
AU2001267638A1 true AU2001267638A1 (en) 2002-03-14
AU2001267638B2 AU2001267638B2 (en) 2006-06-29

Family

ID=8851237

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6763801A Pending AU6763801A (en) 2000-06-14 2001-06-13 Combinatorial production of nucleotide and nucleoside (xitp)analogues
AU2001267638A Ceased AU2001267638B2 (en) 2000-06-14 2001-06-13 Combinatorial production of nucleotide and nucleoside (xitp)analogues

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU6763801A Pending AU6763801A (en) 2000-06-14 2001-06-13 Combinatorial production of nucleotide and nucleoside (xitp)analogues

Country Status (14)

Country Link
US (2) US7319148B2 (en)
EP (2) EP1290006B1 (en)
JP (2) JP4460216B2 (en)
AT (1) ATE354581T1 (en)
AU (2) AU6763801A (en)
CA (1) CA2411036A1 (en)
DE (1) DE60126762T2 (en)
DK (1) DK1290006T3 (en)
ES (1) ES2282266T3 (en)
FR (1) FR2810322B1 (en)
MX (1) MXPA02011896A (en)
NZ (1) NZ523090A (en)
PT (1) PT1290006E (en)
WO (1) WO2001096354A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI332956B (en) * 2002-04-26 2010-11-11 Gilead Sciences Inc Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
ATE490788T1 (en) 2003-04-25 2010-12-15 Gilead Sciences Inc ANTIVIRAL PHOSPHONATE ANALOGUE
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
MXPA05011296A (en) 2003-04-25 2006-01-24 Gilead Sciences Inc Kinase inhibitor phosphonate conjugates.
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7427636B2 (en) 2003-04-25 2008-09-23 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
CA2734052A1 (en) * 2003-05-30 2005-01-13 Pharmasset, Inc. Modified fluorinated nucleoside analogues
US7947817B2 (en) * 2003-06-30 2011-05-24 Roche Molecular Systems, Inc. Synthesis and compositions of 2'-terminator nucleotides
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
JP2007508843A (en) 2003-10-24 2007-04-12 ギリアード サイエンシーズ， インコーポレイテッド Methods and compositions for the identification of therapeutic compounds
WO2005044279A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Purine nucleoside phosphonate conjugates
US20080287471A1 (en) 2003-12-22 2008-11-20 Maria Fardis 4'-Substituted Carbovir And Abacavir-Derivatives As Well As Related Compounds With Hiv And Hcv Antiviral Activity
US7745125B2 (en) 2004-06-28 2010-06-29 Roche Molecular Systems, Inc. 2′-terminator related pyrophosphorolysis activated polymerization
CN101023094B (en) * 2004-07-21 2011-05-18 法莫赛特股份有限公司 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
ES2720618T3 (en) 2004-07-27 2019-07-23 Gilead Sciences Inc Phosphonate analogs of HIV inhibitor compounds
RU2433124C2 (en) * 2004-09-14 2011-11-10 Фармассет, Инк. Methods of producing 2'-fluoro-2'-alkyl-substituted or other substituted ribofuranosyl pyrimidines and purines and derivatives thereof
WO2008067002A2 (en) * 2006-09-11 2008-06-05 Southern Research Institute Azole nucleosides and use as inhibitors of rna and dna varial polymerases
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
UA103329C2 (en) 2008-07-08 2013-10-10 Гилиад Сайенсиз, Инк. Normal;heading 1;heading 2;heading 3;SALTS OF HIV INHIBITOR COMPOUNDS
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
EA201100851A1 (en) 2008-12-23 2012-04-30 Фармассет, Инк. NUCLEOSIDE ANALOGUES
CL2009002206A1 (en) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compounds derived from pyrrolo - (2-3-d] -pyrimidin-7 (6h) -tetrahydrofuran-2-yl phosphonamidate, pharmaceutical composition; and its use in the treatment of viral diseases.
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (en) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 Nucleoside phosphoramidates
BR112012024884A2 (en) 2010-03-31 2016-10-18 Gilead Pharmasset Llc stereo-selective synthesis of phosphorus-containing assets
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
AR084044A1 (en) 2010-11-30 2013-04-17 Pharmasset Inc 2’-ESPIRO-NUCLEOSID COMPOUNDS
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
ES2792503T3 (en) 2013-08-27 2020-11-11 Gilead Pharmasset Llc Combined formulation of two antiviral compounds
PL3661937T3 (en) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections

Similar Documents

Publication Publication Date Title
AU2001267638A1 (en) Combinatorial production of nucleotide and nucleoside (xitp)analogues
AU2001282522A1 (en) Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
HUP0105367A3 (en) Novel nucleosides and oligonucleotide analogues
AU2003211953A1 (en) Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof
AU2002252183A1 (en) Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
AU2001238030A1 (en) Detection of single nucleotide polymorphisms
AU2001247414A1 (en) Oligonucleotide analogues, methods of synthesis and methods of use
GB0128526D0 (en) Nucleotide analogues
AU2002363144A1 (en) Enhanced in vitro nucleic acid synthesis using nucleoside monophosphates
AU2002305073A1 (en) Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids
AU2002214477A1 (en) Modified nucleosides and nucleotides and use thereof
AU2002257446A1 (en) Antiviral nucleosides
AU2001259131A1 (en) Detection of nucleotide sequence variations via the proofreading activity of polymerases
AU3769000A (en) High-throughput gene cloning and phenotypic screening
AU2002357876A1 (en) Nucleoside analog libraries and compounds
AU2001210599A1 (en) High precision and intellectual biochip arrayer having function of respotting
EP1551972A4 (en) Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
AU2653200A (en) Stereoselective synthesis of nucleoside analogues
AU2001284902A1 (en) Human adenosine deaminase
EP1490381A4 (en) Human gene critical to fertility
AUPR079700A0 (en) Combinatorial libraries of monosaccharides
AU2001291975A1 (en) Use of a nucleic acid/pei complex
PL369327A1 (en) Synthesis of 2-aralkoxy adenosines and 2-alkoxyadenosines
AU2405300A (en) Uses of flavivirus rna-dependent rna polymerases
AU2001296471A1 (en) High-throughput gene cloning and phenotypic screening